229 related articles for article (PubMed ID: 31625269)
1. The Machado-Joseph disease deubiquitylase ataxin-3 interacts with LC3C/GABARAP and promotes autophagy.
Herzog LK; Kevei É; Marchante R; Böttcher C; Bindesbøll C; Lystad AH; Pfeiffer A; Gierisch ME; Salomons FA; Simonsen A; Hoppe T; Dantuma NP
Aging Cell; 2020 Jan; 19(1):e13051. PubMed ID: 31625269
[TBL] [Abstract][Full Text] [Related]
2. Fibroblasts of Machado Joseph Disease patients reveal autophagy impairment.
Onofre I; Mendonça N; Lopes S; Nobre R; de Melo JB; Carreira IM; Januário C; Gonçalves AF; de Almeida LP
Sci Rep; 2016 Jun; 6():28220. PubMed ID: 27328712
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado-Joseph disease.
Nascimento-Ferreira I; Santos-Ferreira T; Sousa-Ferreira L; Auregan G; Onofre I; Alves S; Dufour N; Colomer Gould VF; Koeppen A; Déglon N; Pereira de Almeida L
Brain; 2011 May; 134(Pt 5):1400-15. PubMed ID: 21478185
[TBL] [Abstract][Full Text] [Related]
4. Citalopram Reduces Aggregation of ATXN3 in a YAC Transgenic Mouse Model of Machado-Joseph Disease.
Ashraf NS; Duarte-Silva S; Shaw ED; Maciel P; Paulson HL; Teixeira-Castro A; Costa MDC
Mol Neurobiol; 2019 May; 56(5):3690-3701. PubMed ID: 30187384
[TBL] [Abstract][Full Text] [Related]
5. Functional genomics and biochemical characterization of the C. elegans orthologue of the Machado-Joseph disease protein ataxin-3.
Rodrigues AJ; Coppola G; Santos C; Costa Mdo C; Ailion M; Sequeiros J; Geschwind DH; Maciel P
FASEB J; 2007 Apr; 21(4):1126-36. PubMed ID: 17234717
[TBL] [Abstract][Full Text] [Related]
6. Autophagy Promoted the Degradation of Mutant ATXN3 in Neurally Differentiated Spinocerebellar Ataxia-3 Human Induced Pluripotent Stem Cells.
Ou Z; Luo M; Niu X; Chen Y; Xie Y; He W; Song B; Xian Y; Fan D; OuYang S; Sun X
Biomed Res Int; 2016; 2016():6701793. PubMed ID: 27847820
[TBL] [Abstract][Full Text] [Related]
7. The Machado-Joseph disease deubiquitylase ATX-3 couples longevity and proteostasis.
Kuhlbrodt K; Janiesch PC; Kevei É; Segref A; Barikbin R; Hoppe T
Nat Cell Biol; 2011 Mar; 13(3):273-81. PubMed ID: 21317884
[TBL] [Abstract][Full Text] [Related]
8. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of FKH-2/FOXG1 is neuroprotective in a C. elegans model of Machado-Joseph disease.
Fardghassemi Y; Parker JA
Exp Neurol; 2021 Mar; 337():113544. PubMed ID: 33290777
[TBL] [Abstract][Full Text] [Related]
10. Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein.
Ashraf NS; Sutton JR; Yang Y; Ranxhi B; Libohova K; Shaw ED; Barget AJ; Todi SV; Paulson HL; Costa MDC
Neurobiol Dis; 2020 Apr; 137():104697. PubMed ID: 31783119
[TBL] [Abstract][Full Text] [Related]
11. The Machado-Joseph Disease Deubiquitinase Ataxin-3 Regulates the Stability and Apoptotic Function of p53.
Liu H; Li X; Ning G; Zhu S; Ma X; Liu X; Liu C; Huang M; Schmitt I; Wüllner U; Niu Y; Guo C; Wang Q; Tang TS
PLoS Biol; 2016 Nov; 14(11):e2000733. PubMed ID: 27851749
[TBL] [Abstract][Full Text] [Related]
12. Deregulation of autophagy in postmortem brains of Machado-Joseph disease patients.
Sittler A; Muriel MP; Marinello M; Brice A; den Dunnen W; Alves S
Neuropathology; 2018 Apr; 38(2):113-124. PubMed ID: 29218765
[TBL] [Abstract][Full Text] [Related]
13. Calpain Inhibition Is Protective in Machado-Joseph Disease Zebrafish Due to Induction of Autophagy.
Watchon M; Yuan KC; Mackovski N; Svahn AJ; Cole NJ; Goldsbury C; Rinkwitz S; Becker TS; Nicholson GA; Laird AS
J Neurosci; 2017 Aug; 37(32):7782-7794. PubMed ID: 28687604
[TBL] [Abstract][Full Text] [Related]
14. Physiological and pathophysiological characteristics of ataxin-3 isoforms.
Weishäupl D; Schneider J; Peixoto Pinheiro B; Ruess C; Dold SM; von Zweydorf F; Gloeckner CJ; Schmidt J; Riess O; Schmidt T
J Biol Chem; 2019 Jan; 294(2):644-661. PubMed ID: 30455355
[TBL] [Abstract][Full Text] [Related]
15. ATX-3, CDC-48 and UBXN-5: a new trimolecular complex in Caenorhabditis elegans.
Rodrigues AJ; Neves-Carvalho A; Ferro A; Rokka A; Corthals G; Logarinho E; Maciel P
Biochem Biophys Res Commun; 2009 Sep; 386(4):575-81. PubMed ID: 19545544
[TBL] [Abstract][Full Text] [Related]
16. Rescue of ATXN3 neuronal toxicity in
Fardghassemi Y; Tauffenberger A; Gosselin S; Parker JA
Dis Model Mech; 2017 Dec; 10(12):1465-1480. PubMed ID: 29061563
[TBL] [Abstract][Full Text] [Related]
17. Toward therapeutic targets for SCA3: Insight into the role of Machado-Joseph disease protein ataxin-3 in misfolded proteins clearance.
Li X; Liu H; Fischhaber PL; Tang TS
Prog Neurobiol; 2015 Sep; 132():34-58. PubMed ID: 26123252
[TBL] [Abstract][Full Text] [Related]
18. Lysine 117 on ataxin-3 modulates toxicity in Drosophila models of Spinocerebellar Ataxia Type 3.
Blount JR; Patel NC; Libohova K; Harris AL; Tsou WL; Sujkowski A; Todi SV
J Neurol Sci; 2023 Nov; 454():120828. PubMed ID: 37865002
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometry allows rapid detection of protein aggregates in cellular and zebrafish models of spinocerebellar ataxia 3.
Robinson KJ; Tym MC; Hogan A; Watchon M; Yuan KC; Plenderleith SK; Don EK; Laird AS
Dis Model Mech; 2021 Oct; 14(10):. PubMed ID: 34473252
[TBL] [Abstract][Full Text] [Related]
20. ULK overexpression mitigates motor deficits and neuropathology in mouse models of Machado-Joseph disease.
Vasconcelos-Ferreira A; Martins IM; Lobo D; Pereira D; Lopes MM; Faro R; Lopes SM; Verbeek D; Schmidt T; Nóbrega C; Pereira de Almeida L
Mol Ther; 2022 Jan; 30(1):370-387. PubMed ID: 34298131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
